Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life: The key role of the dermatologist.
Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life: The key role of the dermatologist.
复制标题
观点:临终时潜在低风险基底细胞癌 (BCC) 的护理:皮肤科医生的关键作用。
DOI:
10.1016/j.jaad.2015.02.005
复制
发表时间:
2015
影响因子:
13.8
通讯作者:
Chren,Mary-Margaret
中科院分区:
文献类型:
--
作者:
Linos,Eleni;Berger,Timothy;Chren,Mary-Margaret
Unnecessary health care at the end of life is a problem well recognized in many areas of medicine including the care of prostate cancer, breast cancer, and elective surgeries. 1–3 Treatments and tests may be unnecessary or even inappropriate if they involve risks that outweigh potential benefits. For example, mammography is no longer recommended in women who have less than 10 years to live, given the known risks and limited benefits of screening. 4 To target services to those who may benefit, many guidelines now recommend incorporating life expectancy into clinical decisions. 1, 4, 5 As dermatologists who care for patients with low-risk tumors, such as small (< 1 cm) nodular and superficial basal cell carcinomas (BCCs), we need to think about this issue for our own specialty.Some difficult questions we often face as clinicians include: Is this patient too frail to be referred for Mohs? How do I make that decisione—and what if I am wrong? What do I do when my medical recommendation does not match what the patient or family wants? Should cost ever be a consideration in treatment decision-making? How do I document this without getting sued?